Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings, Inc. is a U.S.-based medical technology company listed on the NYSE as common stock under the ticker ZBH. Through its subsidiaries, the company develops, manufactures, and markets products used in orthopedic and related surgical care. Its portfolio includes knee and hip reconstructive products, sports medicine and biologics solutions, foot and ankle, upper extremity, trauma, craniomaxillofacial, and thoracic products, along with bone cement and surgical products. Zimmer Biomet also provides digital and robotic technologies that use data analytics and artificial intelligence to support surgical planning and care decisions. Its offerings are used to treat conditions involving bones, joints, and supporting soft tissues, and are sold to orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, distributors, dealers, and other purchasing organizations. The company was formerly known as Zimmer Holdings, Inc., adopted its current name in June 2015, and was founded in 1927. It is headquartered in Warsaw, Indiana.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.